Clinical Trial Update: Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating pimonidazole hydrochloride to detect low oxygen in tuberculosis-infected lungs has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Pimonidazole hydrochloride (pimonidazole hydrochloride)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Refractory Pulmonary Tuberculosis | Phase 2 | Status: WITHDRAWN